The global market for Intranasal Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intranasal Drug Delivery System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intranasal Drug Delivery System by region & country, by Type, and by Application.

The Intranasal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug Delivery System.

Market Segmentation

Scope of Intranasal Drug Delivery System - Market Report

Report Metric	Details
Report Name	Intranasal Drug Delivery System - Market
CAGR	5%
Segment by Type:	Nasal Drops Nasal Sprays Nasal Gels Nasal Suspensions and Emulsion Nasal Powders
Segment by Application	Hospital Clinic Home Care Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC, H&T Presspart Manufacturing Ltd., AstraZeneca Plc, Becton, BD, Novartis AG, Vectura Group Plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intranasal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intranasal Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intranasal Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Intranasal Drug Delivery System - Market report?

Ans: The main players in the Intranasal Drug Delivery System - Market are Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC, H&T Presspart Manufacturing Ltd., AstraZeneca Plc, Becton, BD, Novartis AG, Vectura Group Plc

What are the Application segmentation covered in the Intranasal Drug Delivery System - Market report?

Ans: The Applications covered in the Intranasal Drug Delivery System - Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Intranasal Drug Delivery System - Market report?

Ans: The Types covered in the Intranasal Drug Delivery System - Market report are Nasal Drops, Nasal Sprays, Nasal Gels, Nasal Suspensions and Emulsion, Nasal Powders

1 Market Overview

1.1 Intranasal Drug Delivery System Product Introduction

1.2 Global Intranasal Drug Delivery System Market Size Forecast

1.2.1 Global Intranasal Drug Delivery System Sales Value (2019-2030)

1.2.2 Global Intranasal Drug Delivery System Sales Volume (2019-2030)

1.2.3 Global Intranasal Drug Delivery System Sales Price (2019-2030)

1.3 Intranasal Drug Delivery System Market Trends & Drivers

1.3.1 Intranasal Drug Delivery System Industry Trends

1.3.2 Intranasal Drug Delivery System Market Drivers & Opportunity

1.3.3 Intranasal Drug Delivery System Market Challenges

1.3.4 Intranasal Drug Delivery System Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Intranasal Drug Delivery System Players Revenue Ranking (2023)

2.2 Global Intranasal Drug Delivery System Revenue by Company (2019-2024)

2.3 Global Intranasal Drug Delivery System Players Sales Volume Ranking (2023)

2.4 Global Intranasal Drug Delivery System Sales Volume by Company Players (2019-2024)

2.5 Global Intranasal Drug Delivery System Average Price by Company (2019-2024)

2.6 Key Manufacturers Intranasal Drug Delivery System Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Intranasal Drug Delivery System Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Intranasal Drug Delivery System

2.9 Intranasal Drug Delivery System Market Competitive Analysis

2.9.1 Intranasal Drug Delivery System Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Intranasal Drug Delivery System Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Nasal Drops

3.1.2 Nasal Sprays

3.1.3 Nasal Gels

3.1.4 Nasal Suspensions and Emulsion

3.1.5 Nasal Powders

3.2 Global Intranasal Drug Delivery System Sales Value by Type

3.2.1 Global Intranasal Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Intranasal Drug Delivery System Sales Value, by Type (2019-2030)

3.2.3 Global Intranasal Drug Delivery System Sales Value, by Type (%) (2019-2030)

3.3 Global Intranasal Drug Delivery System Sales Volume by Type

3.3.1 Global Intranasal Drug Delivery System Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Intranasal Drug Delivery System Sales Volume, by Type (2019-2030)

3.3.3 Global Intranasal Drug Delivery System Sales Volume, by Type (%) (2019-2030)

3.4 Global Intranasal Drug Delivery System Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Home Care

4.1.4 Others

4.2 Global Intranasal Drug Delivery System Sales Value by Application

4.2.1 Global Intranasal Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Intranasal Drug Delivery System Sales Value, by Application (2019-2030)

4.2.3 Global Intranasal Drug Delivery System Sales Value, by Application (%) (2019-2030)

4.3 Global Intranasal Drug Delivery System Sales Volume by Application

4.3.1 Global Intranasal Drug Delivery System Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Intranasal Drug Delivery System Sales Volume, by Application (2019-2030)

4.3.3 Global Intranasal Drug Delivery System Sales Volume, by Application (%) (2019-2030)

4.4 Global Intranasal Drug Delivery System Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Intranasal Drug Delivery System Sales Value by Region

5.1.1 Global Intranasal Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Intranasal Drug Delivery System Sales Value by Region (2019-2024)

5.1.3 Global Intranasal Drug Delivery System Sales Value by Region (2025-2030)

5.1.4 Global Intranasal Drug Delivery System Sales Value by Region (%), (2019-2030)

5.2 Global Intranasal Drug Delivery System Sales Volume by Region

5.2.1 Global Intranasal Drug Delivery System Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Intranasal Drug Delivery System Sales Volume by Region (2019-2024)

5.2.3 Global Intranasal Drug Delivery System Sales Volume by Region (2025-2030)

5.2.4 Global Intranasal Drug Delivery System Sales Volume by Region (%), (2019-2030)

5.3 Global Intranasal Drug Delivery System Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Intranasal Drug Delivery System Sales Value, 2019-2030

5.4.2 North America Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Intranasal Drug Delivery System Sales Value, 2019-2030

5.5.2 Europe Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Intranasal Drug Delivery System Sales Value, 2019-2030

5.6.2 Asia Pacific Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Intranasal Drug Delivery System Sales Value, 2019-2030

5.7.2 South America Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Intranasal Drug Delivery System Sales Value, 2019-2030

5.8.2 Middle East & Africa Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Intranasal Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Intranasal Drug Delivery System Sales Value

6.2.1 Key Countries/Regions Intranasal Drug Delivery System Sales Value, 2019-2030

6.2.2 Key Countries/Regions Intranasal Drug Delivery System Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Intranasal Drug Delivery System Sales Value, 2019-2030

6.3.2 United States Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Intranasal Drug Delivery System Sales Value, 2019-2030

6.4.2 Europe Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Intranasal Drug Delivery System Sales Value, 2019-2030

6.5.2 China Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.5.3 China Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Intranasal Drug Delivery System Sales Value, 2019-2030

6.6.2 Japan Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Intranasal Drug Delivery System Sales Value, 2019-2030

6.7.2 South Korea Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Intranasal Drug Delivery System Sales Value, 2019-2030

6.8.2 Southeast Asia Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Intranasal Drug Delivery System Sales Value, 2019-2030

6.9.2 India Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

6.9.3 India Intranasal Drug Delivery System Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Aptar Pharma

7.1.1 Aptar Pharma Company Information

7.1.2 Aptar Pharma Introduction and Business Overview

7.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Aptar Pharma Intranasal Drug Delivery System Product Offerings

7.1.5 Aptar Pharma Recent Development

7.2 Nemera

7.2.1 Nemera Company Information

7.2.2 Nemera Introduction and Business Overview

7.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Nemera Intranasal Drug Delivery System Product Offerings

7.2.5 Nemera Recent Development

7.3 Teleflex

7.3.1 Teleflex Company Information

7.3.2 Teleflex Introduction and Business Overview

7.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Teleflex Intranasal Drug Delivery System Product Offerings

7.3.5 Teleflex Recent Development

7.4 Mystic Pharmaceuticals

7.4.1 Mystic Pharmaceuticals Company Information

7.4.2 Mystic Pharmaceuticals Introduction and Business Overview

7.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Product Offerings

7.4.5 Mystic Pharmaceuticals Recent Development

7.5 Zeteo Medical

7.5.1 Zeteo Medical Company Information

7.5.2 Zeteo Medical Introduction and Business Overview

7.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Zeteo Medical Intranasal Drug Delivery System Product Offerings

7.5.5 Zeteo Medical Recent Development

7.6 Johnson & Johnson

7.6.1 Johnson & Johnson Company Information

7.6.2 Johnson & Johnson Introduction and Business Overview

7.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Johnson & Johnson Intranasal Drug Delivery System Product Offerings

7.6.5 Johnson & Johnson Recent Development

7.7 GlaxoSmithKline Plc

7.7.1 GlaxoSmithKline Plc Company Information

7.7.2 GlaxoSmithKline Plc Introduction and Business Overview

7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Product Offerings

7.7.5 GlaxoSmithKline Plc Recent Development

7.8 Aegis Therapeutics LLC

7.8.1 Aegis Therapeutics LLC Company Information

7.8.2 Aegis Therapeutics LLC Introduction and Business Overview

7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Product Offerings

7.8.5 Aegis Therapeutics LLC Recent Development

7.9 H&T Presspart Manufacturing Ltd.

7.9.1 H&T Presspart Manufacturing Ltd. Company Information

7.9.2 H&T Presspart Manufacturing Ltd. Introduction and Business Overview

7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Offerings

7.9.5 H&T Presspart Manufacturing Ltd. Recent Development

7.10 AstraZeneca Plc

7.10.1 AstraZeneca Plc Company Information

7.10.2 AstraZeneca Plc Introduction and Business Overview

7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Product Offerings

7.10.5 AstraZeneca Plc Recent Development

7.11 Becton

7.11.1 Becton Company Information

7.11.2 Becton Introduction and Business Overview

7.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Becton Intranasal Drug Delivery System Product Offerings

7.11.5 Becton Recent Development

7.12 BD

7.12.1 BD Company Information

7.12.2 BD Introduction and Business Overview

7.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.12.4 BD Intranasal Drug Delivery System Product Offerings

7.12.5 BD Recent Development

7.13 Novartis AG

7.13.1 Novartis AG Company Information

7.13.2 Novartis AG Introduction and Business Overview

7.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Novartis AG Intranasal Drug Delivery System Product Offerings

7.13.5 Novartis AG Recent Development

7.14 Vectura Group Plc

7.14.1 Vectura Group Plc Company Information

7.14.2 Vectura Group Plc Introduction and Business Overview

7.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Vectura Group Plc Intranasal Drug Delivery System Product Offerings

7.14.5 Vectura Group Plc Recent Development

8 Industry Chain Analysis

8.1 Intranasal Drug Delivery System Industrial Chain

8.2 Intranasal Drug Delivery System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Intranasal Drug Delivery System Sales Model

8.5.2 Sales Channel

8.5.3 Intranasal Drug Delivery System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Aptar Pharma

Nemera

Teleflex

Mystic Pharmaceuticals

Johnson & Johnson

GlaxoSmithKline PLC

Aegis Therapeutics LLC

H&T Presspart Manufacturing Ltd

List of Tables

Table 1. Intranasal Drug Delivery System Market Trends

Table 2. Intranasal Drug Delivery System Market Drivers & Opportunity

Table 3. Intranasal Drug Delivery System Market Challenges

Table 4. Intranasal Drug Delivery System Market Restraints

Table 5. Global Intranasal Drug Delivery System Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Intranasal Drug Delivery System Revenue Market Share by Company (2019-2024)

Table 7. Global Intranasal Drug Delivery System Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Intranasal Drug Delivery System Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Intranasal Drug Delivery System Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Intranasal Drug Delivery System Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Intranasal Drug Delivery System Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Intranasal Drug Delivery System

Table 13. Global Intranasal Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Intranasal Drug Delivery System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Intranasal Drug Delivery System Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Intranasal Drug Delivery System Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Intranasal Drug Delivery System Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Intranasal Drug Delivery System Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Intranasal Drug Delivery System Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Intranasal Drug Delivery System Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Intranasal Drug Delivery System Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Intranasal Drug Delivery System Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Intranasal Drug Delivery System Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Intranasal Drug Delivery System Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Intranasal Drug Delivery System Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Intranasal Drug Delivery System Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Intranasal Drug Delivery System Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Intranasal Drug Delivery System Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Intranasal Drug Delivery System Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Intranasal Drug Delivery System Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Intranasal Drug Delivery System Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Intranasal Drug Delivery System Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Intranasal Drug Delivery System Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Intranasal Drug Delivery System Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Intranasal Drug Delivery System Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Intranasal Drug Delivery System Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Intranasal Drug Delivery System Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Intranasal Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Intranasal Drug Delivery System Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Intranasal Drug Delivery System Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Intranasal Drug Delivery System Sales Value by Region (2019-2024) & (%)

Table 44. Global Intranasal Drug Delivery System Sales Value by Region (2025-2030) & (%)

Table 45. Global Intranasal Drug Delivery System Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Intranasal Drug Delivery System Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Intranasal Drug Delivery System Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Intranasal Drug Delivery System Sales Volume by Region (2019-2024) & (%)

Table 49. Global Intranasal Drug Delivery System Sales Volume by Region (2025-2030) & (%)

Table 50. Global Intranasal Drug Delivery System Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Intranasal Drug Delivery System Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Intranasal Drug Delivery System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Intranasal Drug Delivery System Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Intranasal Drug Delivery System Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Intranasal Drug Delivery System Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Intranasal Drug Delivery System Sales Volume, (2025-2030) & (K Units)

Table 57. Aptar Pharma Company Information

Table 58. Aptar Pharma Introduction and Business Overview

Table 59. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Aptar Pharma Intranasal Drug Delivery System Product Offerings

Table 61. Aptar Pharma Recent Development

Table 62. Nemera Company Information

Table 63. Nemera Introduction and Business Overview

Table 64. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Nemera Intranasal Drug Delivery System Product Offerings

Table 66. Nemera Recent Development

Table 67. Teleflex Company Information

Table 68. Teleflex Introduction and Business Overview

Table 69. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Teleflex Intranasal Drug Delivery System Product Offerings

Table 71. Teleflex Recent Development

Table 72. Mystic Pharmaceuticals Company Information

Table 73. Mystic Pharmaceuticals Introduction and Business Overview

Table 74. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Mystic Pharmaceuticals Intranasal Drug Delivery System Product Offerings

Table 76. Mystic Pharmaceuticals Recent Development

Table 77. Zeteo Medical Company Information

Table 78. Zeteo Medical Introduction and Business Overview

Table 79. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Zeteo Medical Intranasal Drug Delivery System Product Offerings

Table 81. Zeteo Medical Recent Development

Table 82. Johnson & Johnson Company Information

Table 83. Johnson & Johnson Introduction and Business Overview

Table 84. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Johnson & Johnson Intranasal Drug Delivery System Product Offerings

Table 86. Johnson & Johnson Recent Development

Table 87. GlaxoSmithKline Plc Company Information

Table 88. GlaxoSmithKline Plc Introduction and Business Overview

Table 89. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. GlaxoSmithKline Plc Intranasal Drug Delivery System Product Offerings

Table 91. GlaxoSmithKline Plc Recent Development

Table 92. Aegis Therapeutics LLC Company Information

Table 93. Aegis Therapeutics LLC Introduction and Business Overview

Table 94. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Aegis Therapeutics LLC Intranasal Drug Delivery System Product Offerings

Table 96. Aegis Therapeutics LLC Recent Development

Table 97. H&T Presspart Manufacturing Ltd. Company Information

Table 98. H&T Presspart Manufacturing Ltd. Introduction and Business Overview

Table 99. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Offerings

Table 101. H&T Presspart Manufacturing Ltd. Recent Development

Table 102. AstraZeneca Plc Company Information

Table 103. AstraZeneca Plc Introduction and Business Overview

Table 104. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. AstraZeneca Plc Intranasal Drug Delivery System Product Offerings

Table 106. AstraZeneca Plc Recent Development

Table 107. Becton Company Information

Table 108. Becton Introduction and Business Overview

Table 109. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Becton Intranasal Drug Delivery System Product Offerings

Table 111. Becton Recent Development

Table 112. BD Company Information

Table 113. BD Introduction and Business Overview

Table 114. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. BD Intranasal Drug Delivery System Product Offerings

Table 116. BD Recent Development

Table 117. Novartis AG Company Information

Table 118. Novartis AG Introduction and Business Overview

Table 119. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Novartis AG Intranasal Drug Delivery System Product Offerings

Table 121. Novartis AG Recent Development

Table 122. Vectura Group Plc Company Information

Table 123. Vectura Group Plc Introduction and Business Overview

Table 124. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Vectura Group Plc Intranasal Drug Delivery System Product Offerings

Table 126. Vectura Group Plc Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Intranasal Drug Delivery System Downstream Customers

Table 130. Intranasal Drug Delivery System Distributors List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Intranasal Drug Delivery System Product Picture

Figure 2. Global Intranasal Drug Delivery System Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Intranasal Drug Delivery System Sales Volume (2019-2030) & (K Units)

Figure 5. Global Intranasal Drug Delivery System Sales Price (2019-2030) & (US$/Unit)

Figure 6. Intranasal Drug Delivery System Report Years Considered

Figure 7. Global Intranasal Drug Delivery System Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Intranasal Drug Delivery System Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intranasal Drug Delivery System Revenue in 2023

Figure 10. Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Nasal Drops Picture

Figure 12. Nasal Sprays Picture

Figure 13. Nasal Gels Picture

Figure 14. Nasal Suspensions and Emulsion Picture

Figure 15. Nasal Powders Picture

Figure 16. Global Intranasal Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Intranasal Drug Delivery System Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Intranasal Drug Delivery System Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Intranasal Drug Delivery System Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Intranasal Drug Delivery System Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Clinic

Figure 23. Product Picture of Home Care

Figure 24. Product Picture of Others

Figure 25. Global Intranasal Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Intranasal Drug Delivery System Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Intranasal Drug Delivery System Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Intranasal Drug Delivery System Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Intranasal Drug Delivery System Price by Application (2019-2030) & (US$/Unit)

Figure 30. North America Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Intranasal Drug Delivery System Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Intranasal Drug Delivery System Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Intranasal Drug Delivery System Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Intranasal Drug Delivery System Sales Volume (%), (2019-2030)

Figure 42. United States Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 48. China Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 50. China Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 60. India Intranasal Drug Delivery System Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Intranasal Drug Delivery System Sales Value by Type (%), 2023 VS 2030

Figure 62. India Intranasal Drug Delivery System Sales Value by Application (%), 2023 VS 2030

Figure 63. Intranasal Drug Delivery System Industrial Chain

Figure 64. Intranasal Drug Delivery System Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions